🕵️ U S Physical Therapy Inc /NV ($USPH)
SEC insider & ownership activity, last 12 months · CIK 885978 · every row links its SEC filing
Over the last 12 months insiders sold $499K against $325K of open-market buying. Kathleen A. Gilmartin bought $276K in discretionary trades (Nov). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
2 buyers, $325K (5 lots) · 2 sellers, $499K (5 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Kathleen A. Gilmartin | 1 | $276K | 0 | – | Nov 20, 2025 |
| Graham D. Reeve | 0 | – | 4 | $254K | Mar 11, 2026 |
| Richard Binstein | 0 | – | 1 | $245K | Mar 6, 2026 |
| Minan Peter Francis | 4 | $49K | 0 | – | Sep 11, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| BlackRock, Inc. | 14.2% | 13G | Jul 18, 2025 | filing ↗ | |
| Kayne Anderson Rudnick Investment Management, LLC | 5.6% | 13G | Aug 13, 2026 | filing ↗ | |
| Copeland Capital Management | 5.5% | 13G | Aug 4, 2026 | filing ↗ | |
| Vanguard Capital Management | 5.1% | 13G | Apr 30, 2026 | filing ↗ | |
| BAHL & Gaynor Inc | 5.1% | 13G | May 8, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Graham Reeve | $155K | Mar 11, 2026 | filing ↗ |
| Richard Binstein | $245K | Mar 6, 2026 | filing ↗ |
| Graham Reeve | $149K | Mar 6, 2026 | filing ↗ |
| Graham D. Reeve | $53K | Nov 21, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Aug 12, 2026 | filing ↗ |
| Officer/director changes (5.02) | Aug 12, 2026 | filing ↗ |
| Other events (8.01) | Aug 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 6, 2026 | filing ↗ |
| Earnings (2.02) | Aug 5, 2026 | filing ↗ |
| Other events (8.01) | Aug 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 5, 2026 | filing ↗ |
| Other events (8.01) | Jul 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 1, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 19, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Earnings (2.02) | May 6, 2026 | filing ↗ |
| Other events (8.01) | May 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 6, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 14, 2026 | filing ↗ |
| New financial obligation (2.03) | Apr 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 14, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 9, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 6, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 25, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 25, 2026 | filing ↗ |